via Mayo Clinic
More than 38 million Americans suffer from migraine. It is the sixth most disabling neurologic disease globally, according to the World Health Organization.
Yet, migraine often is undiagnosed and left untreated. Dr. Amaal Starling, a neurologist at Mayo Clinic, says because the neurologic disease is so incapacitating, it is important to have a variety of treatment options. Dr. Starling is the lead author of a new study that looked at single pulse transcranial magnetic stimulation for the preventive treatment of migraine.
A migraine. It’s much more than a headache. And it can be debilitating.
“It’s a neurologic disease that has light sensitivity, sound sensitivity, motion sensitivity, nausea, vomiting. There are so many components,” says Dr. Starling.
There is no cure for migraine but there is a new option cleared by the U.S. Food and Drug Administration for the acute and preventive treatment of migraine.
“The device is called a single-pulse transcranial magnetic stimulation device,” says Dr. Starling.
She says the device transmits a signal to the brain, reducing brain hyperexcitability.
“Place it on the back of the head just like that [beeping]’ and then you push these two buttons,” says Dr. Starling. “And that administers a pulse.”
The first step, says Dr. Starling, is to get people with migraine to their health care provider so they can be properly diagnosed and treated.
Learn more: Mayo Clinic Minute: New device can prevent migraine attacks
The Latest on: Migraine
[google_news title=”” keyword=”migraine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Migraine
- Migraine: Know About Its Early Signs And Symptomson September 27, 2023 at 12:00 pm
Migraines are complex neurological processes that can impact your life, not just severe headaches. Read on to know.
- Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Tevaon September 27, 2023 at 9:54 am
T he verdict, which had favored Teva Pharmaceutical (NYSE: TEVA), had found that Lilly's migraine drug, Emgality, infringed upon three patents related to Teva's rival drug, Ajovy. U.S. District Judge ...
- Global Acute Migraine Drugs Market Size Targets USD 9.26 Billion by 2030 with a 8.90% CAGR | Rising Need for Prevention & Treatment of Migraineon September 27, 2023 at 7:04 am
Newark, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The global acute migraine drugs market is expected to grow from 4.3 billion in 2021 to USD 9.26 billion by 2030, at a CAGR of 8.90% during the forecast ...
- The complex link between migraine and heart diseaseon September 26, 2023 at 2:59 am
Migraine, a neurological disorder characterised by severe and recurrent headaches, has long been a subject of medical interest due to its debilitating nature. Recent research has unveiled a complex ...
- Global Migraine Nasal Spray Market slated to reach US$ 983.5 million by 2033, expanding at a 7% CAGR | Future Market Insights, Inc.on September 25, 2023 at 6:30 am
According to a study by Future Market Insights, the worldwide migraine nasal spray market is anticipated to expand at a CAGR of 7.0% during the forecasted period. By ...
- Migraine must be taken seriously as waiting times for treatment rise – charityon September 24, 2023 at 4:01 pm
Migraine must be taken seriously as waiting times for treatment rise – charity - A report by the Migraine Trust called for greater awareness of the condition and treatments.
- Migraine headaches increase risk of stroke and heart attacks, study showson September 21, 2023 at 12:34 am
Researchers say women who experience migraine headaches have a slightly higher risk of heart attack or hemorrhagic stroke than men ...
- Magnesium and B2 stopped my daily headaches. Now I'm pain-free and go weeks without a migraine.on September 19, 2023 at 5:22 am
Magnesium is helpful for headaches, studies have shown. Taking it along with a B2 supplement helped stop my daily migraines and go weeks without pain.
- It’s the Best Time in History to Have a Migraineon September 19, 2023 at 4:01 am
These days, migraine sufferers are caught in a bit of a paradox. In some ways, their situation looks bright (but, please, not too bright): More treatments are available now than ever before—though ...
via Bing News
